Common use of U.S. Resolution Stay Protocol Clause in Contracts

U.S. Resolution Stay Protocol. The parties have previously adhered to the ISDA 2018 U.S. Resolution Stay Protocol as published by the International Swaps and Derivatives Association, Inc. as of July 31, 2018 (the “ISDA U.S. Protocol”), the terms of such protocol shall be incorporated into and form a part of this Confirmation and the terms of the ISDA U.S. Protocol shall supersede and replace the terms of this section. For purposes of incorporating the ISDA U.S. Protocol, Dealer shall be deemed to be a Regulated Entity, Counterparty shall be deemed to be an Adhering Party, and this Confirmation shall be deemed to be a Protocol Covered Agreement. Capitalized terms used but not defined in this paragraph shall have the meanings given to them in the ISDA U.S. Protocol. Counterparty hereby agrees (a) to check this Confirmation carefully and immediately upon receipt so that errors or discrepancies can be promptly identified and rectified and (b) to confirm that the foregoing (in the exact form provided by Dealer) correctly sets forth the terms of the agreement between Dealer and Counterparty with respect to the Transaction, by manually signing this Confirmation or this page hereof as evidence of agreement to such terms and providing the other information requested herein and immediately returning an executed copy to Xxxxxxx Xxxxx & Co. LLC, Equity Derivatives Documentation Department, Facsimile No. (000) 000-0000/83. Very truly yours, XXXXXXX SACHS & CO. LLC By: /s/ Xxxx Xxxxx Name: Xxxx Xxxxx Title: Managing Director Accepted and confirmed as of the Trade Date: SAREPTA THERAPEUTICS, INC. By: /s/ Xxx Xxxxxxx Authorized Signatory

Appears in 2 contracts

Samples: Sarepta Therapeutics, Inc., Sarepta Therapeutics, Inc.

AutoNDA by SimpleDocs

U.S. Resolution Stay Protocol. The parties acknowledge that both parties have previously adhered to the ISDA 2018 U.S. Resolution Stay Protocol and Attachment thereto as published by the International Swaps and Derivatives Association, Inc. as of on July 31, 2018 (the “ISDA U.S. Protocol”), agree that the terms of such protocol shall be the Protocol are incorporated into and form a part of this Confirmation and the terms of the ISDA U.S. agree that, for such purposes, this Confirmation shall be deemed a Protocol shall supersede and replace the terms of this section. For purposes of incorporating the ISDA U.S. ProtocolCovered Agreement, Dealer shall be deemed to be a Regulated Entity, Entity and Counterparty shall be deemed to be an Adhering Party, and . In the event of any inconsistencies between this Confirmation shall be deemed to be a and the terms of the Protocol, the terms of the Protocol Covered Agreementwill govern. Capitalized terms Terms used but not defined in this paragraph without definition shall have the meanings given assigned to them in under the ISDA U.S. Protocol. Counterparty hereby agrees (a) For purposes of this paragraph, references to check this Confirmation carefully and immediately upon receipt so that errors Confirmation” include any related credit enhancements entered into between the parties or discrepancies can be promptly identified and rectified and (b) to confirm that the foregoing (in the exact form provided by Dealer) correctly sets forth one to the other. In addition, the parties agree that the terms of the agreement between this paragraph shall be incorporated into any related Covered Affiliate Credit Enhancements, with all references to Dealer and Counterparty with respect replaced by references to the Transactioncovered affiliate support provider. Yours sincerely, by manually signing this Confirmation or this page hereof as evidence of agreement to such terms and providing the other information requested herein and immediately returning an executed copy to Xxxxxxx Xxxxx & Co. LLCJPMORGAN CHASE BANK, Equity Derivatives Documentation Department, Facsimile No. (000) 000-0000/83. Very truly yours, XXXXXXX SACHS & CO. LLC NATIONAL ASSOCIATION By: /s/ Xxxx Kxxxx X. Xxxxx Name: Xxxx Kxxxx X. Xxxxx Title: Managing Director Accepted and confirmed Vice President Confirmed as of the Trade Datedate first above written: SAREPTA THERAPEUTICS, INC. DUKE ENERGY CORPORATION By: /s/ Xxx Xxxxxxx Authorized SignatoryJxxx X. Xxxxxxxx, III Name: Jxxx X. Xxxxxxxx, III Title: Assistant Treasurer SCHEDULE I FORWARD PRICE REDUCTION DATES AND AMOUNTS Schedule I-1 ANNEX A PRIVATE PLACEMENT PROCEDURES If Counterparty delivers Restricted Shares pursuant to Section 10 above (a “Private Placement Settlement”), then:

Appears in 2 contracts

Samples: Duke Energy CORP, Duke Energy CORP

U.S. Resolution Stay Protocol. The parties have previously adhered to the ISDA 2018 U.S. Resolution Stay Protocol as published by the International Swaps and Derivatives Association, Inc. as of July 31, 2018 (the “ISDA U.S. Protocol”), the terms of such protocol shall be incorporated into and form a part of this Confirmation and the terms of the ISDA U.S. Protocol shall supersede and replace the terms of this section. For purposes of incorporating the ISDA U.S. Protocol, Dealer shall be deemed to be a Regulated Entity, Counterparty shall be deemed to be an Adhering Party, and this Confirmation shall be deemed to be a Protocol Covered Agreement. Capitalized terms used but not defined in this paragraph shall have the meanings given to them in the ISDA U.S. Protocol. Counterparty hereby agrees (a) to check this Confirmation carefully and immediately upon receipt so that errors or discrepancies can be promptly identified and rectified and (b) to confirm that the foregoing (in the exact form provided by Dealer) correctly sets forth the terms of the agreement between Dealer and Counterparty with respect to the Transaction, by manually signing this Confirmation or this page hereof as evidence of agreement to such terms and providing the other information requested herein and immediately returning an executed copy to Xxxxxxx Xxxxx & Co. LLC, Equity Derivatives Documentation Department, Facsimile No. (000) 000-0000/83Dealer. Very truly yours, XXXXXX XXXXXXX SACHS & CO. LLC By: /s/ Xxxx Xxxxx Xxxxxx XxXxxxxx Authorized Signatory Name: Xxxx Xxxxx Title: Managing Director Accepted and confirmed as of the Trade Date: SAREPTA THERAPEUTICS, INC. By: /s/ Xxx Xxxxxxx Authorized Signatory

Appears in 1 contract

Samples: Sarepta Therapeutics, Inc.

AutoNDA by SimpleDocs

U.S. Resolution Stay Protocol. The parties have previously adhered to the ISDA 2018 U.S. Resolution Stay Protocol as published by the International Swaps and Derivatives Association, Inc. as of July 31, 2018 (the “ISDA U.S. Protocol”), the terms of such protocol shall be incorporated into and form a part of this Confirmation and the terms of the ISDA U.S. Protocol shall supersede and replace the terms of this section. For purposes of incorporating the ISDA U.S. Protocol, Dealer shall be deemed to be a Regulated Entity, Counterparty shall be deemed to be an Adhering Party, and this Confirmation shall be deemed to be a Protocol Covered Agreement. Capitalized terms used but not defined in this paragraph shall have the meanings given to them in the ISDA U.S. Protocol. Counterparty hereby agrees (a) to check this Confirmation carefully and immediately upon receipt so that errors or discrepancies can be promptly identified and rectified and (b) to confirm that the foregoing (in the exact form provided by Dealer) correctly sets forth the terms of the agreement between Dealer and Counterparty with respect to the Transaction, by manually signing this Confirmation or this page hereof as evidence of agreement to such terms and providing the other information requested herein and immediately returning an executed copy to Xxxxxxx Xxxxx & Co. LLC, Equity Derivatives Documentation Department, Facsimile No. (000) 000-0000/83Dealer. Very truly yours, XXXXXX XXXXXXX SACHS & CO. LLC By: /s/ Xxxx Xxxxx Xxxxxx XxXxxxxx Name: Xxxx Xxxxx Xxxxxx XxXxxxxx Title: Managing Director Accepted and confirmed as of the Trade Date: SAREPTA THERAPEUTICS, INC. By: /s/ Xxx Xxxxxxx Authorized Signatory

Appears in 1 contract

Samples: Sarepta Therapeutics, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.